Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Medicare will soon start paying lower prices for Novo Nordisk’s weight- loss drug Wegovy and its Type 2 diabetes treatment Ozempic, the federal agency that manages the program said Friday.

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

In one of its last actions, the Biden administration released the next 15 drugs selected for Medicare negotiation and the blockbuster diabetes drug Ozempic will be among those bargained for this year.

Insurers also ask the Trump administration, which is engaged in a sweeping campaign to eradicate anything related to ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

On Friday, the Centers for Medicare & Medicaid Services (CMS ... It includes Novo Nordisk's weight loss and diabetes drugs Wegovy and Ozempic, as well as Xtandi, Ibrance, Calquence and Pomalyst ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for Medicare price negotiations for 2027, the U.S. government said on Friday, part of ...

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden ...

The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...